2016Advances in medical technologies and clinical practice book seriesRequires access

Policy Planning to Support Technological Innovation in the Pharmaceutical Industry

Leong Chan, Dan Liu

Open publisher page 0 citations

Abstract

The pharmaceutical industry is often characterized as a research-driven sector because of its exceptionally high ratio of R&D inputs to sales. Development of novel drugs is very difficult because of several issues including heavy investment, high risks, and long development cycle. Government plays an important role in regulating the development of the pharmaceutical industry. This is true for all phases in pharmaceutical development: from R&D to market. This chapter will focus on the discussion of prospective high-tech areas, development strategies, and innovation resources in the pharmaceutical industry. Expert opinions were analyzed based on the conditions in China's biopharmaceutical sector. Policy recommendations are provided to support technological innovation.

About this research paper

What this paper is about

The pharmaceutical industry is often characterized as a research-driven sector because of its exceptionally high ratio of R&D inputs to sales. Development of novel drugs is very difficult because of several issues including heavy investment, high risks, and long development cycle. Government plays an important role in regulating the development of the pharmaceutical industry. This is true for all phases in pharmaceutical development: from R&D to market. This chapter will focus on the discussion of prospective high-tech areas, development strategies, and innovation resources in the pharmaceutical industry. Expert opinions were analyzed based on the conditions in China's biopharmaceutical sector. Policy recommendations are provided to support technological innovation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The pharmaceutical industry is often characterized as a research-driven sector because of its exceptionally high ratio of R&D inputs to sales. Development of novel drugs is very difficult because of several issues including heavy investment, high risks, and long development cycle. Government plays an important role in regulating the development of the pharmaceutical industry. This is true for all phases in pharmaceutical development: from R&D to market. This chapter will focus on the discussion of prospective high-tech areas, development strategies, and innovation resources in the pharmaceutical industry. Expert opinions were analyzed based on the conditions in China's biopharmaceutical sector. Policy recommendations are provided to support technological innovation.

Key concepts: Pharmaceutical industry, Biopharmaceutical, Business, Investment (military), Government (linguistics), Industrial organization, Political science, Biotechnology

Related papers

Back to paper searchBrowse research topicsOriginal source
Policy Planning to Support Technological Innovation in the Pharmaceutical Industry — Research Paper | ScholarLens